Pharmacological Effects of JTT-551, a Novel Protein Tyrosine Phosphatase 1B Inhibitor, in Diet-Induced Obesity Mice
Main Authors: | Makoto Ito, Sumiaki Fukuda, Shohei Sakata, Hisayo Morinaga, Takeshi Ohta |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2014-01-01
|
Series: | Journal of Diabetes Research |
Online Access: | http://dx.doi.org/10.1155/2014/680348 |
Similar Items
-
JTT-130, a Novel Intestine-Specific Inhibitor of Microsomal Triglyceride Transfer Protein, Improves Hyperglycemia and Dyslipidemia Independent of Suppression of Food Intake in Diabetic Rats
by: Shohei Sakata, et al.
Published: (2014-01-01) -
JTT-553, a novel Acyl CoA:diacylglycerol acyltransferase (DGAT) 1 inhibitor, improves glucose metabolism in diet-induced obesity and genetic T2DM mice
by: Daisuke Tomimoto, et al.
Published: (2015-09-01) -
JTT-130, a Novel Intestine-Specific Inhibitor of Microsomal Triglyceride Transfer Protein, Reduces Food Preference for Fat
by: Yasuko Mera, et al.
Published: (2014-01-01) -
JTT-130, a novel intestine-specific inhibitor of microsomal triglyceride transfer protein, ameliorates lipid metabolism and attenuates atherosclerosis in hyperlipidemic animal models
by: Yasuko Mera, et al.
Published: (2015-11-01) -
Proteinaceous Regulators and Inhibitors of Protein Tyrosine Phosphatases
by: Wiljan Hendriks, et al.
Published: (2018-02-01)